ALLYRNA

Hong Kong, Hong Kong · Founded 2025 · Privately Held (backing)

Developer of RNA-based biopharmaceutical technologies intended to accelerate therapeutic innovation in precision medicine. ALLYRNA is based in Hong Kong, Hong Kong and was founded in 2025. It has raised $10 million.

Last price · $/share
—
Implied valuation
—
Total raised
$10.0M
Last round
—

Who backs ALLYRNA?

4 investors
InvestorType
Plaisance CapitalHedge fund
Gaorong Ventures—
Jifeng Ventures—
Qiji Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

ALLYRNA investors

4 investors are on record for ALLYRNA, including Plaisance Capital, Gaorong Ventures, Jifeng Ventures and Qiji Investment.

Free account
More of ALLYRNA with a free account
  • ·Watch ALLYRNA: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like ALLYRNA. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View